These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24794658)

  • 1. The newer contraceptive pills and venous thromboembolism risk.
    Foran TM
    Med J Aust; 2014 Apr; 200(7):376-7. PubMed ID: 24794658
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peroral hormonal contraception and risk of venous thromboembolism].
    Ludka O; Spinar J; Musil V; Pozdísek Z
    Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
    Vinogradova Y; Coupland C; Hippisley-Cox J
    BMJ; 2015 May; 350():h2135. PubMed ID: 26013557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
    Plu-Bureau G; Sabbagh E; Hugon-Rodin J
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Contraceptive Methods for Obese and Overweight Women.
    Lotke PS; Kaneshiro B
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):647-57. PubMed ID: 26598306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile and recurrence rate in women with venous thromboembolism during combined hormonal contraceptive use: a prospective cohort study.
    van Vlijmen EF; Mäkelburg AB; Knol HM; Tichelaar VI; Kluin-Nelemans HC; Veeger NJ; Meijer K
    Br J Haematol; 2016 Feb; 172(4):636-8. PubMed ID: 26105591
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serious adverse effect of combined oral contraceptive pills among teenagers].
    Nylander MC; Clausen HV
    Ugeskr Laeger; 2014 Jun; 176(26):V05130336. PubMed ID: 25294576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fresh evidence confirms links between newer contraceptive pills and higher risk of venous thromboembolism.
    Jick SS
    BMJ; 2015 May; 350():h2422. PubMed ID: 26013974
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined hormonal contraception and venous thromboembolism.
    Martínez F; Avecilla A
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of hormonal contraception on prothrombotic activity in vessels.
    Gacka M; Adamiec R
    Int Angiol; 2014 Oct; 33(5):485-93. PubMed ID: 24769552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European agency defends existing advice on later generation contraceptive pills.
    Arie S
    BMJ; 2013 Jan; 346():f279. PubMed ID: 23319580
    [No Abstract]   [Full Text] [Related]  

  • 12. Sex hormones and venous thromboembolism - from contraception to hormone replacement therapy.
    Beyer-Westendorf J; Bauersachs R; Hach-Wunderle V; Zotz RB; Rott H
    Vasa; 2018 Oct; 47(6):441-450. PubMed ID: 30008249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive for obese women: considerations.
    Kelsey B
    Nurse Pract; 2010 Mar; 35(3):24-31; quiz 31-2. PubMed ID: 20164732
    [No Abstract]   [Full Text] [Related]  

  • 14. Query about Faculty updated UKMEC.
    Lee DJ
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):181; author reply 181. PubMed ID: 20659387
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral contraception and venous thromboembolism. A New Zealand perspective.
    Roke C
    Drug Saf; 1997 Feb; 16(2):79-87. PubMed ID: 9067120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eligibility criteria in venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
    Dore DD; Norman H; Seeger JD
    Obstet Gynecol; 2009 Jul; 114(1):175. PubMed ID: 19546793
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
    Raymond EG; Burke AE; Espey E
    Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clarification concerning NuvaRing].
    Jonsson M
    Lakartidningen; 2007 Jan 31-Feb 6; 104(5):355. PubMed ID: 17328363
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination oral contraceptives and the risk of venous thromboembolism.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):23-4. PubMed ID: 20336034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.